GADSDEN REPORT
Don't Tread On The Truth
Economy & Markets

FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss

Source: FOX BIZ 0 views 0 comments
The Food and Drug Administration now requires warning labels on Ozempic, Wegovy and other GLP-1 drugs over a rare eye condition tied to vision loss. Read more at FOX BIZ ›
Read the full story at
FOX BIZ
Open the original

The Gadsden Report aggregates and summarises headlines. The reporting above belongs to FOX BIZ, and the link opens their page. This page exists so readers can find, share, and discuss the story here.

US evacuates air refueling tankers from UK base over security concerns: Report [EXAMINER]
Rewards platform Bilt announces 'next evolution' for American consumers, small businesses [FOX BIZ]
China is stealing our medicines, and Americans are paying the price [EXAMINER]
More than 1.2M Ford vehicles under federal probe after safety feature causes severe burns, 10 injured [FOX BIZ]
California amusement park to close after more than 50 years [FOX BIZ]
Nvidia case highlights risks of alleged 'honeypot' schemes targeting executives [FOX BIZ]

Discussion — 0 comments

No comments yet. Be the first.